Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2000
01/19/2000EP0971950A2 Secreted proteins and polynucleotides encoding them
01/19/2000EP0971949A1 Complexes and combinations of fetuin with therapeutic agents
01/19/2000EP0971948A2 Inhibitors for urokinase receptor
01/19/2000EP0971946A1 Selection of proteins using rna-protein fusions
01/19/2000EP0971742A1 Obesity protein formulations
01/19/2000EP0971740A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use
01/19/2000EP0971738A1 Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants
01/19/2000EP0971736A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination
01/19/2000EP0971734A1 Carbohydrate antigens which immunoreact with polyclonal antisera against h. pylori
01/19/2000EP0971726A1 Peptides for inhibiting retroviruses
01/19/2000EP0971723A1 Compositions and methods for inhibiting cellular proliferation
01/19/2000EP0971700A1 Identification of the progression elevated gene-3 and uses thereof
01/19/2000EP0971580A1 Regulatory element for expressing genes in plants
01/19/2000EP0971579A1 Plant pathogen response gene
01/19/2000EP0955807A4 Dna and encoded protein which regulates cold and dehydration regulated genes
01/19/2000EP0897392A4 Isolation and use of sh3 binding peptides
01/19/2000EP0851870A4 Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides
01/19/2000EP0814826A4 Compositions and methods for reducing adhesiveness of defective red blood cells
01/19/2000EP0772631A4 Processes for the purification of human recombinant decorin and the detection of guanidinium ions
01/19/2000EP0713395A4 Polymeric carriers for non-covalent drug conjugation
01/19/2000EP0654086B1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants
01/19/2000EP0625989B1 Dna sequences encoding novel growth/differentiation factors
01/19/2000EP0587873B1 Process for the production of cells infected by a multiple sclerosis associated virus
01/19/2000EP0532587B1 Methods for trans-destabilization of specific proteins in vivo
01/19/2000EP0515536B1 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules
01/19/2000CN1242055A Method for the detection of compounds that modulate the effects of the OB3se (OB) protein
01/19/2000CN1242053A Vaccines
01/19/2000CN1242049A Multi-functional chimeric hematopoletic receptor agonists
01/19/2000CN1242047A Compound and methods for diagnosis of tuberculosis
01/19/2000CN1242046A Mammalian cytokine related to IL10
01/19/2000CN1242045A Immunotherapy and improved vaccines
01/19/2000CN1242044A Stable expression of triple helical proteins
01/19/2000CN1242043A Receptor ligand VEGF-C
01/19/2000CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors
01/19/2000CN1241635A New escherichia coli host/vector system based on antibiotic free selection by conplementation of auxotrophy
01/19/2000CN1241572A Preparation of nerve growth factor
01/19/2000CN1048523C Method for preparing viral protein generated from hepatitisvirokine
01/18/2000US6015942 Transforming cells of susceptible plant with chimeric recombinant dna which encodes a coat protein from cucumber mosaic virus, regenerating plants, identifying transformants; one viral gene confers resistance to several viruses
01/18/2000US6015941 Peptide derivatives of tachyplesin having antimicrobial activity
01/18/2000US6015940 Virus resistant potato plants
01/18/2000US6015938 Osteoprotegerin
01/18/2000US6015904 Stable reagents for the preparation of radio pharmaceuticals
01/18/2000US6015897 For conjugation to ligand/antiligand pair and use in delivery of therapeutic or diagnostic agent to targeted site
01/18/2000US6015892 Nucleotide sequences for diagnosis and treatment of related disorders; antisense/anticarcinogenic/antitumor agents; antiinflammatory/antiproliferative agents
01/18/2000US6015891 Synthetic insecticidal crystal protein gene having a modified frequency of codon usage
01/18/2000US6015889 Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
01/18/2000US6015888 Allele of human histamine H2 receptor and methods of detection of H2 receptor variants
01/18/2000US6015887 Chiral peptide nucleic acids and methods for preparing same
01/18/2000US6015884 Soluble divalent and multivalent heterodimeric analogs of proteins
01/18/2000US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents
01/18/2000US6015882 Amino acid sequence of antigen gp900 detected at the surface of cryptosporidium sporozoites or merozoites; for antiprotozoa agents
01/18/2000US6015881 Methods and compositions for peptide synthesis
01/18/2000US6015878 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application
01/18/2000US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate
01/18/2000US6015795 Bovine viral diarrhea virus II vaccine and method of immunization
01/18/2000US6015794 Trans-splicing ribozymes
01/18/2000US6015788 Diagnosis and treatment of alzheimer's disease and various autoimmune disorders such as sle, systemic lupus erythematosus
01/18/2000US6015787 Cell-permeable protein inhibitors of calpain
01/18/2000US6015785 Aglucone isofavone enriched vegetable protein extract and isolate and process for producing
01/18/2000US6015714 Efficient sequencing of nucleic acids by using two separate but adjacent pools of medium with an interface having channel allowing sequential nucleotide passage, taking measurements as each nucleotide passes through the channel
01/18/2000US6015713 Transgenic fish and a method of harvesting islet cells therefrom
01/18/2000US6015711 Smooth muscle 22α promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells
01/18/2000US6015710 Specific nucleobase sequences; for administration to mammalian cells in vitro
01/18/2000US6015709 Nucleic acid which encodes a transcription factor including transcription activation domains and a dna binding domain; for high-level expression of a target gene in genetically engineered cells
01/18/2000US6015708 Yeast artificial chromosome with mammalian dna including target gene and heterologous regulatory sequence; for expression in a mammalian cell and high yield of product with less manipulation
01/18/2000US6015707 Treating cellulosic materials with cellulases from chrysosporium
01/18/2000US6015705 Method of modifying the DNA of an organism, DNA sequence, method of detection and isolation of a gene capable of modifying the DNA of an organism and organisms comprising modified DNA
01/18/2000US6015702 Nucleotide and amino acid sequences; for diagnosis, prevention and treatment of neoplastic, developmental, immune and nervous system disorders; anticarcinogenic/antitumor/ antisense agents
01/18/2000US6015696 Mycobacterium bovis bcg that has been transformed with a vector comprising a promoter, a signal sequence, a dna sequence encoding a heterologous polypeptide, and a replicator region; for vaccines
01/18/2000US6015695 Immunoglobulins devoid of light chains
01/18/2000US6015694 Method for stimulating an immune response utilizing recombinant alphavirus particles
01/18/2000US6015693 Recombinant production of soluble TGF-β-binding endoglin polypeptides
01/18/2000US6015692 Nucleic acid which encodes a recombinant polypeptide capable of binding cyclin-dependent kinase and extracellular-signal related kinase; for diagnosis of proliferative disorders; antiproliferative/anticarcinogenic agents
01/18/2000US6015691 Nucleotide and amino acid sequences; for diagnosis and treatment of infections; for vaccines
01/18/2000US6015690 DNA sequence encoding a human imidazoline receptor and method for cloning the same
01/18/2000US6015689 Amino acid sequences of protein controlling sensitivity of fungus to fungicide; for diagnosis and treatment of mycoses
01/18/2000US6015688 Transferrin receptor genes
01/18/2000US6015687 Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof
01/18/2000US6015686 A eukaryotic promoter 5' of viral cdna which initiates within a cell the 5' to 3' synthesis of rna from complementary dna producing a vector construct which autonomously amplifies in a cell and expresses an heterologous sequence; gene therapy
01/18/2000US6015685 Ancrod proteins, their preparation and use
01/18/2000US6015682 Factors which modify gene transcription and methods of use therefor
01/18/2000US6015680 Human lung adenocarcinoma-related monoclonal antibody and immunoassay method which uses the same
01/18/2000US6015678 Method for detection of a polynucleotide encoding protein kinase C inhibitor-homolog
01/18/2000US6015677 Assay methods using DNA encoding mammalian phosphodiesterases
01/18/2000US6015672 Rab-specific guanine-nucleotide dissociation inhibitor
01/18/2000US6015669 Identification of genes
01/18/2000US6015665 Method and composition for regulating apoptosis
01/18/2000US6015663 Restriction enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains
01/18/2000US6015660 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
01/18/2000US6015572 Glial cells with neurotropic factors for nerve damage
01/18/2000US6015567 HER2 extracellular domain
01/18/2000US6015566 Peptide composition generating an immune response against herpes virus
01/18/2000US6015564 Polypeptides with fatty acid and steroids
01/18/2000US6015561 Antigen binding peptides (abtides) from peptide libraries
01/18/2000US6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function
01/18/2000US6015556 Cytotoxic drug therapy
01/18/2000US6015552 Use of nerve growth factor-2 (NGF-2) /neurotrophin-3 (NT-3) to promote leukocyte proliferation
01/18/2000US6015542 Radioimmunotherapy of lymphoma using anti-CD20 antibodies
01/18/2000CA2195095C Regulated expression of heterologous genes in plants and transgenic fruit with a modified ripening phenotype
01/18/2000CA2132954C Modified ciliary neurotrophic factors